Speaker illustration

Professor Jorge Bartolucci

Los Andes University, Santiago (Chile)

Phase 1/2 randomized clinical trial of intravenous infusion of umbilical cord mesenchymal stem cells in patients with chronic cardiopathy with stable heart failure (RIMECARD)

Event: ESC CONGRESS 2016

Topic: Heart failure, other

Session: Heart failure


This platform is supported by

logo Novo Nordisk